UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000034701
Receipt number R000039563
Scientific Title Add-on treatment of dutasteridey to tadalafil for patients with benign prostatic enlargement
Date of disclosure of the study information 2018/11/01
Last modified on 2023/01/29 15:44:04

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Add-on treatment of dutasteridey to tadalafil for patients with benign prostatic enlargement

Acronym

Add-on treatment of dutasteridey to tadalafil for patients with benign prostatic enlargement

Scientific Title

Add-on treatment of dutasteridey to tadalafil for patients with benign prostatic enlargement

Scientific Title:Acronym

Add-on treatment of dutasteridey to tadalafil for patients with benign prostatic enlargement

Region

Japan


Condition

Condition

Benign prostatic hyperplasia

Classification by specialty

Urology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine the add-on effect of dutasteride to tadalafil for patients with BPH

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Improvement of IPSS

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Add-on treatment of dutasteride

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

50 years-old <=

Age-upper limit

100 years-old >

Gender

Male

Key inclusion criteria

Patinets with 30ml over of prostate volume and IPSS>8 or QOL>3 by 3months of tadalafil treatment

Key exclusion criteria

Patients who don't accept the study

Target sample size

50


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Naoki Wada

Organization

Asahikawa Medical University

Division name

Department or Renal and Urologic Surgery

Zip code


Address

2-1 Higashi Midorigaoka Asahikawa

TEL

0166-68-2533

Email

nwada@asahikawa-med.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Naoki Wada

Organization

Asahikawa Medical University

Division name

Department or Renal and Urologic Surgery

Zip code


Address

2-1 Higashi Midorigaoka Asahikawa

TEL

0166-68-2533

Homepage URL


Email

nwada@asahikawa-med.ac.jp


Sponsor or person

Institute

Asahikawa Medical University

Institute

Department

Personal name



Funding Source

Organization

Asahikawa Medical University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 11 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 11 Month 01 Day

Date of IRB

2016 Year 10 Month 30 Day

Anticipated trial start date

2016 Year 11 Month 01 Day

Last follow-up date

2020 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 10 Month 30 Day

Last modified on

2023 Year 01 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000039563


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name